169 related articles for article (PubMed ID: 35594511)
1. Inclusion of sarcopenia improves the prognostic value of MELD score in patients after transjugular intrahepatic portosystemic shunt.
Bai YW; Liu JC; Yang CT; Wang YL; Wang CY; Ju SG; Zhou C; Huang SJ; Li TQ; Chen Y; Yao W; Xiong B
Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):948-955. PubMed ID: 35594511
[TBL] [Abstract][Full Text] [Related]
2. MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation.
Song J; Wang X; Yan Y; Xiang T; Luo X
Dig Dis Sci; 2023 Jul; 68(7):3185-3192. PubMed ID: 36715817
[TBL] [Abstract][Full Text] [Related]
3. Validating the prognostic value of Freiburg index of posttransjugular intrahepatic portosystemic shunt survival score and classic scores in Chinese patients with implantation of transjugular intrahepatic portosystemic shunt.
Song J; Wang X; Yan Y; Xiang T; Luo X
Eur J Gastroenterol Hepatol; 2022 Oct; 34(10):1074-1080. PubMed ID: 36062497
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study.
Zhang B; Cai W; Gao F; Lin X; Qian T; Gu K; Song B; Chen T
Med Sci Monit; 2022 Jan; 28():e934057. PubMed ID: 35031594
[TBL] [Abstract][Full Text] [Related]
5. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.
Lee BT; Yang AH; Urban S; Kim KY; Ter-Oganesyan R; Yuan L; Han HH; Khemichian S; Kahn JA; Kim B
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):541-546. PubMed ID: 32398491
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
[TBL] [Abstract][Full Text] [Related]
7. The Added Value of Sarcopenia on Existing Risk Scores to Predict Mortality after TIPS Placement: A Multicenter Study.
Xiong B; Yang C; Zhu X; Zhou C; Chen S; Zhang Z; Wu X; Huang S
Acad Radiol; 2023 Sep; 30 Suppl 1():S246-S256. PubMed ID: 37029067
[TBL] [Abstract][Full Text] [Related]
8. Early Liver Failure after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis with Model for End-Stage Liver Disease Score of 12 or Less: Incidence, Outcome, and Prognostic Factors.
Luca A; Miraglia R; Maruzzelli L; D'Amico M; Tuzzolino F
Radiology; 2016 Aug; 280(2):622-9. PubMed ID: 26982564
[TBL] [Abstract][Full Text] [Related]
9. Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites.
Hu XG; Yang XX; Lu J; Li G; Dai JJ; Wang JM; Deng Y; Feng R
World J Gastrointest Surg; 2024 Feb; 16(2):481-490. PubMed ID: 38463353
[TBL] [Abstract][Full Text] [Related]
10. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
[TBL] [Abstract][Full Text] [Related]
11. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
Bettinger D; Sturm L; Pfaff L; Hahn F; Kloeckner R; Volkwein L; Praktiknjo M; Lv Y; Han G; Huber JP; Boettler T; Reincke M; Klinger C; Caca K; Heinzow H; Seifert LL; Weiss KH; Rupp C; Piecha F; Kluwe J; Zipprich A; Luxenburger H; Neumann-Haefelin C; Schmidt A; Jansen C; Meyer C; Uschner FE; Brol MJ; Trebicka J; Rössle M; Thimme R; Schultheiss M
J Hepatol; 2021 Jun; 74(6):1362-1372. PubMed ID: 33508376
[TBL] [Abstract][Full Text] [Related]
12. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.
Shoreibah MG; Mahmoud K; Aboueldahab NA; Vande Lune P; Massoud M; Bae S; El Khudari H; Gunn AJ; Abdel Aal AK
J Vasc Interv Radiol; 2019 Feb; 30(2):154-161. PubMed ID: 30717946
[TBL] [Abstract][Full Text] [Related]
13. FIPS Score for Prediction of Survival After TIPS Placement: External Validation and Comparison With Traditional Risk Scores in a Cohort of Chinese Patients With Cirrhosis.
Yang C; Chen Q; Zhou C; Liu J; Huang S; Wang Y; Wang C; Ju S; Chen Y; Li T; Bai Y; Yao W; Xiong B
AJR Am J Roentgenol; 2022 Aug; 219(2):255-267. PubMed ID: 35138134
[No Abstract] [Full Text] [Related]
14. Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt.
March C; Thormann M; Geipel S; Sowa JP; Barajas Ordonez F; Pech M; Omari J; Lemmer P
Sci Rep; 2023 Oct; 13(1):17092. PubMed ID: 37816875
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhosis patients undergoing transjugular intrahepatic portosystemic shunt.
Zhang W; Aryan M; Chen Z; Khan W; Thompson B; Kwenda E; Geller B; Morelli G
Eur J Gastroenterol Hepatol; 2022 Apr; 34(4):435-442. PubMed ID: 34750323
[TBL] [Abstract][Full Text] [Related]
16. Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding.
Walter A; Rudler M; Olivas P; Moga L; Trépo E; Robic MA; Ollivier-Hourmand I; Baiges A; Sutter O; Bouzbib C; Peron JM; Le Pennec V; Ganne-Carrié N; Garcia-Pagán JC; Mallet M; Larrue H; Dao T; Thabut D; Hernández-Gea V; Nault JC; Bureau C; Allaire M;
Hepatology; 2021 Oct; 74(4):2085-2101. PubMed ID: 34018627
[TBL] [Abstract][Full Text] [Related]
17. Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment.
Alessandria C; Gaia S; Marzano A; Venon WD; Fadda M; Rizzetto M
Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):607-12. PubMed ID: 15167164
[TBL] [Abstract][Full Text] [Related]
18. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.
Ascha M; Hanouneh M; S Ascha M; Zein NN; Sands M; Lopez R; Hanouneh IA
Dig Dis Sci; 2017 Feb; 62(2):534-542. PubMed ID: 27154510
[TBL] [Abstract][Full Text] [Related]
19. MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.
Young S; Rostambeigi N; Golzarian J; Lim N
AJR Am J Roentgenol; 2020 Jul; 215(1):215-222. PubMed ID: 32432911
[No Abstract] [Full Text] [Related]
20. Relative Sarcopenia With Excess Adiposity Predicts Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.
Ronald J; Bozdogan E; Zaki IH; Kappus MR; Choi SS; Martin JG; Suhocki PV; Smith TP; Kim CY; Bashir MR
AJR Am J Roentgenol; 2020 Jan; 214(1):200-205. PubMed ID: 31670594
[No Abstract] [Full Text] [Related]
[Next] [New Search]
